Tinyteddy,
Thanks for this insightful and accurate analysis.
Here are some important aspects to consider that may not be obvious from the release:
(1) Wehave previously shown that Nasodine kills the SARS-CoV-2 virus in vitro, i.e., in a laboratory setting. However, invitro results very often do not translate to clinical results in humans. The current study confirms that the effect does translate in vivo for Nasodine, which is an importantfinding.
(2) It is also important to appreciate that we were assessing viral load, not just in the nose, but also the throat. We believed it was important to show clearance of virus from the entire upper respiratory tract and not just the nasal passages. This made the outcome more challenging, but Nasodine did not disappoint.
(3) As stated in the release, COVID-19 won’t be the last global pandemic. Nasodine is a broad-spectrum nasal spray that kills all viruses, and enveloped viruses (all pandemic viruses are enveloped) are acutely sensitive to Nasodine. Therefore, we believe Nasodine will play a crucial role in the next pandemic, because it will be active against any pandemic virus and it does lead to viral resistance.
PM
- Forums
- ASX - By Stock
- Ann: Firebrick Covid-19 Trial Achieves Primary Endpoint
FRE
firebrick pharma limited
Add to My Watchlist
14.3%
!
6.0¢

Tinyteddy,Thanks for this insightful and accurate analysis.Here...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
6.0¢ |
Change
-0.010(14.3%) |
Mkt cap ! $13.47M |
Open | High | Low | Value | Volume |
6.9¢ | 6.9¢ | 6.0¢ | $14.43K | 234.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 50062 | 6.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.9¢ | 1716 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 50062 | 0.061 |
2 | 214685 | 0.060 |
2 | 30000 | 0.059 |
1 | 100000 | 0.057 |
2 | 143832 | 0.056 |
Price($) | Vol. | No. |
---|---|---|
0.069 | 1716 | 1 |
0.080 | 47101 | 2 |
0.088 | 5758 | 2 |
0.089 | 15000 | 1 |
0.090 | 100 | 1 |
Last trade - 14.40pm 26/06/2025 (20 minute delay) ? |
Featured News
FRE (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online